antibody cd105-pe cy7 sn6 Search Results


pe-cy7  (Bioss)
90
Bioss pe-cy7
Porcine panel.
Pe Cy7, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-cy7/product/Bioss
Average 90 stars, based on 1 article reviews
pe-cy7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105-pe-cy7  (Thermo Fisher)
90
Thermo Fisher cd105-pe-cy7
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Cd105 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105-pe-cy7/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cd105-pe-cy7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105 pe/cy7 antibody  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology cd105 pe/cy7 antibody
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Cd105 Pe/Cy7 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105 pe/cy7 antibody/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
cd105 pe/cy7 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-mouse cd105-pe-cy7  (Thermo Fisher)
90
Thermo Fisher anti-mouse cd105-pe-cy7
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Anti Mouse Cd105 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-mouse cd105-pe-cy7/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-mouse cd105-pe-cy7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105 pe cy7  (Thermo Fisher)
86
Thermo Fisher cd105 pe cy7
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Cd105 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105 pe cy7/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
cd105 pe cy7 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
alexa 647 anti-sca1  (Thermo Fisher)
90
Thermo Fisher alexa 647 anti-sca1
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Alexa 647 Anti Sca1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa 647 anti-sca1/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
alexa 647 anti-sca1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105 pe cy7  (Danaher Inc)
86
Danaher Inc cd105 pe cy7
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Cd105 Pe Cy7, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105 pe cy7/product/Danaher Inc
Average 86 stars, based on 1 article reviews
cd105 pe cy7 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
anti mouse cd105 pe cy7  (Thermo Fisher)
86
Thermo Fisher anti mouse cd105 pe cy7
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Anti Mouse Cd105 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd105 pe cy7/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
anti mouse cd105 pe cy7 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
anti-cd105-pe 9811-09  (SouthernBiotech)
90
SouthernBiotech anti-cd105-pe 9811-09
a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − <t>CD105</t> + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.
Anti Cd105 Pe 9811 09, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd105-pe 9811-09/product/SouthernBiotech
Average 90 stars, based on 1 article reviews
anti-cd105-pe 9811-09 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105-pe  (Thermo Fisher)
90
Thermo Fisher cd105-pe
Keratocytes and ADSCs characterization. ( a ) Light microscopy photographs of cultured keratocytes with dendritic morphology. ( b ) The gene expression profile demonstrated higher expression of positive keratocyte markers, including Lumican ( LUM ), Keratocan ( KERA ), ALDH3A1 , and CD34 and minimal expression of myofibroblast marker ( ACTA2 ) in keratocytes and ADSCs. ( c , d ) Immunofluorescence images of human keratocytes cultured for Keratocan (green)/lumican (red)/nuclei (DAPI, blue), and α-SMA (green)/nuclei (DAPI, blue). ( e ) Representative of average protein levels. ( f ) Light inverted microscopy photographs of ADSCs with spindle shape morphology. ( g ) Flow cytometry results showing up-expression of <t>CD105,</t> CD73, CD90, and down-expression of CD45 in hADSCs.
Cd105 Pe, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105-pe/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cd105-pe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105-pe  (R&D Systems)
90
R&D Systems cd105-pe
Keratocytes and ADSCs characterization. ( a ) Light microscopy photographs of cultured keratocytes with dendritic morphology. ( b ) The gene expression profile demonstrated higher expression of positive keratocyte markers, including Lumican ( LUM ), Keratocan ( KERA ), ALDH3A1 , and CD34 and minimal expression of myofibroblast marker ( ACTA2 ) in keratocytes and ADSCs. ( c , d ) Immunofluorescence images of human keratocytes cultured for Keratocan (green)/lumican (red)/nuclei (DAPI, blue), and α-SMA (green)/nuclei (DAPI, blue). ( e ) Representative of average protein levels. ( f ) Light inverted microscopy photographs of ADSCs with spindle shape morphology. ( g ) Flow cytometry results showing up-expression of <t>CD105,</t> CD73, CD90, and down-expression of CD45 in hADSCs.
Cd105 Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105-pe/product/R&D Systems
Average 90 stars, based on 1 article reviews
cd105-pe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd105-pe  (Becton Dickinson)
90
Becton Dickinson cd105-pe
Keratocytes and ADSCs characterization. ( a ) Light microscopy photographs of cultured keratocytes with dendritic morphology. ( b ) The gene expression profile demonstrated higher expression of positive keratocyte markers, including Lumican ( LUM ), Keratocan ( KERA ), ALDH3A1 , and CD34 and minimal expression of myofibroblast marker ( ACTA2 ) in keratocytes and ADSCs. ( c , d ) Immunofluorescence images of human keratocytes cultured for Keratocan (green)/lumican (red)/nuclei (DAPI, blue), and α-SMA (green)/nuclei (DAPI, blue). ( e ) Representative of average protein levels. ( f ) Light inverted microscopy photographs of ADSCs with spindle shape morphology. ( g ) Flow cytometry results showing up-expression of <t>CD105,</t> CD73, CD90, and down-expression of CD45 in hADSCs.
Cd105 Pe, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd105-pe/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd105-pe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Porcine panel.

Journal: Frontiers in Immunology

Article Title: Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy

doi: 10.3389/fimmu.2020.00826

Figure Lengend Snippet: Porcine panel.

Article Snippet: CD105 , PE-cy7 , Bioss Antibodies.

Techniques:

Human panel.

Journal: Frontiers in Immunology

Article Title: Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy

doi: 10.3389/fimmu.2020.00826

Figure Lengend Snippet: Human panel.

Article Snippet: CD105 , PE-cy7 , Bioss Antibodies.

Techniques:

a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − CD105 + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.

Journal: NPJ Regenerative Medicine

Article Title: Notch-Wnt signal crosstalk regulates proliferation and differentiation of osteoprogenitor cells during intramembranous bone healing

doi: 10.1038/s41536-021-00139-x

Figure Lengend Snippet: a Histological section of tibial mono-cortical defects 5 days after injury, stained with Movat’s Pentachrome. The defect site is filled with soft tissue. b PCNA IHC shows active proliferation in the periosteum and defect site at this early time point. c Alkaline phosphatase staining demonstrates only a small region of osteogenic differentiation at the cortical edge. d After 14 days, the defects site is filled with woven bone, stained yellow-green with Pentachrome. e PCNA staining reveals absence of proliferation within the injury. f Alkaline phosphatase staining indicating osteogenic differentiation throughout the injury site. g Quantification of PCNA-positive cells in the injury site at POD 5 and 14. h Quantification of alkaline phosphatase staining at POD 5 and 14. i Frequency of bone-cartilage-stromal progenitor cells (BCSPs) was analyzed over the time course of fracture healing by flow cytometry using the following BCSP markers: CD45 − Ter119 − Tie2 − CD51 + CD90 − 6C3 − CD105 + . Scale bar = 100 μm. ALP alkaline phosphatase, BCSP bone-cartilage-stromal progenitor cells, c cortical bone, PCNA proliferating cell nuclear antigen, POD postoperative day. ** p < 0.01. Data were represented as mean ± s.e.m.

Article Snippet: CD105-PE-Cy7 , Thermo Fisher Scientific , 1:200.

Techniques: Staining, Flow Cytometry

Antibodies for flow cytometry.

Journal: NPJ Regenerative Medicine

Article Title: Notch-Wnt signal crosstalk regulates proliferation and differentiation of osteoprogenitor cells during intramembranous bone healing

doi: 10.1038/s41536-021-00139-x

Figure Lengend Snippet: Antibodies for flow cytometry.

Article Snippet: CD105-PE-Cy7 , Thermo Fisher Scientific , 1:200.

Techniques: Cytometry

Keratocytes and ADSCs characterization. ( a ) Light microscopy photographs of cultured keratocytes with dendritic morphology. ( b ) The gene expression profile demonstrated higher expression of positive keratocyte markers, including Lumican ( LUM ), Keratocan ( KERA ), ALDH3A1 , and CD34 and minimal expression of myofibroblast marker ( ACTA2 ) in keratocytes and ADSCs. ( c , d ) Immunofluorescence images of human keratocytes cultured for Keratocan (green)/lumican (red)/nuclei (DAPI, blue), and α-SMA (green)/nuclei (DAPI, blue). ( e ) Representative of average protein levels. ( f ) Light inverted microscopy photographs of ADSCs with spindle shape morphology. ( g ) Flow cytometry results showing up-expression of CD105, CD73, CD90, and down-expression of CD45 in hADSCs.

Journal: Scientific Reports

Article Title: An inspired microenvironment of cell replicas to induce stem cells into keratocyte-like dendritic cells for corneal regeneration

doi: 10.1038/s41598-023-42359-9

Figure Lengend Snippet: Keratocytes and ADSCs characterization. ( a ) Light microscopy photographs of cultured keratocytes with dendritic morphology. ( b ) The gene expression profile demonstrated higher expression of positive keratocyte markers, including Lumican ( LUM ), Keratocan ( KERA ), ALDH3A1 , and CD34 and minimal expression of myofibroblast marker ( ACTA2 ) in keratocytes and ADSCs. ( c , d ) Immunofluorescence images of human keratocytes cultured for Keratocan (green)/lumican (red)/nuclei (DAPI, blue), and α-SMA (green)/nuclei (DAPI, blue). ( e ) Representative of average protein levels. ( f ) Light inverted microscopy photographs of ADSCs with spindle shape morphology. ( g ) Flow cytometry results showing up-expression of CD105, CD73, CD90, and down-expression of CD45 in hADSCs.

Article Snippet: ADSCs were stained with conjugated antibodies including CD105-PE (eBioscience; USA), CD90-APC (BioLegend; USA), CD73-PE-Cy7 (BioLegend; USA), and CD45-FITC (BioLegend; USA).

Techniques: Light Microscopy, Cell Culture, Expressing, Marker, Immunofluorescence, Inverted Microscopy, Flow Cytometry